metabolism. Traditionally, microbial biotransformation screening and small scale-ups (< 1L) are performed in shake-flask reactors. An alternative approach is the use of hollow fiber cartridge (HFC) reactors. The performance of HFC reactors is compared to shakeflask reactors using diclofenac as a model substrate. Actinoplanes sp. (ATCC-53771) in a shake-flask reactor hydroxylated diclofenac (50 µM) with 100% turnover in less than 5 hours. A scaled-up production resulted in the formation of 4'-hydroxy (169 mg, 54% yield), 5-hydroxy (42 mg, 13 % yield) and 4',5-dihydroxy (25 mg, 7.7% yield) metabolites. HFC reactors with Teflon, poly-sulfone, and cellulose membranes were screened for non-specific binding of diclofenac. Concentration-time profiles for turnover of 50-2000 µM diclofenac by Actinoplanes sp. were then determined at 22ºC and 30 °C in an HFC reactor. Cellulose-based HFC reactors exhibited the lowest non-specific binding (87% of 50 µM diclofenac remaining after 5 hr) and offered the best conditions for its biotransformation (100% conversion; < 5hr at 30 °C at 50 µM; 25 hr at 500 µM).
The time profile for substrate turnover was equivalent in both a cellulose membrane HFC reactor and shake-flask reactor. Two cellulose membrane HFC reactors were also tested to evaluate the reusability of the cartridges for diclofenac metabolism (50 µM, 22 °C, 15 hr; 500 µM, 30 °C, 36 hr). Up to seven reaction cycles with intermediate wash cycles
were tested. At least 98 % conversion was observed in each reaction cycle at both diclofenac concentrations.
There are several fungal and bacterial microbial systems known to mimic mammalian metabolism of xenobiotics in which the biotransformations are carried out by the constituent cytochrome P450(s). The term "Microbial Models of Mammalian
Metabolism" was coined in the mid-70s by Smith and Rosazza (1974) Microbial fermentation methods typically utilize a two-stage fermentation protocol (Goodhue CT, 1982) . A common approach (Hilton MD, 1999) is to add substrate to a stage II culture in a sterile shake flask, incubate on an orbital shaker for a suitable period of time, quench, centrifuge or filter, and then extract supernatants to obtain the biotransformed products. This method has been successfully used to screen for microbes that make the metabolite of interest as well as perform small scale (< 1 L) biosynthesis with the identified microbe. One shortcoming of this configuration, however, is the destruction of the microbial bio-catalyst when the reaction is quenched, which limits each preparation to a single reaction.
A hollow fiber cartridge (HFC) reactor (described in the experimental section) provides a configuration that isolates a relatively small volume of microbial culture from a larger reservoir of culture medium via a semi-permeable membrane (Knazek et al. 1972) . The membrane permits exchange of nutrients, substrate, and metabolites, and provides two potential advantages of an HFC reactor over a shake-flask system. The excretory products that over time might otherwise inhibit the viability of the microorganism diffuse away from the culture and are diluted by the larger volume of medium in the reservoir.
Also, because the metabolites also diffuse through the capillaries into the circulating medium, they can be harvested without disturbing the bio-catalyst. The bio-catalyst may then be potentially reused many times over.
Diclofenac sodium (Voltaren) is a non-steroidal anti-inflammatory drug widely prescribed anti-inflammatory and anti-pyretic analgesic. Its principal phase-I metabolic This article has not been copyedited and formatted. The final version may differ from this version. products formed in vivo and in vitro in rats, dogs, baboons, and humans, are 4'-hydroxy and 5-hydroxy metabolites (Stierlin et al 1979 , Shen et al. 1999 , Leemann et al. 1993 ).
Minor in vivo oxidative metabolites include 3'-OH and 4',5-dihydroxy diclofenac (Stierlin et al. 1979) .
In this study, we report (1) the efficient turn over of diclofenac to its hydroxylated metabolites by the bacterium Actinoplanes sp. in a shake-flask incubation; (2) use of a shake-flask system to scale-up production of the 4'-hydroxy, 5-hydroxy, and 4',5-dihydroxy metabolites of diclofenac; (3) the efficient use of HFC reactors to produce turnover rates comparable to a shake-flask configuration; and (4) demonstration that an HFC reactor can be reused for many (n > 5 over 10 days) cycles. The following fungi were also screened: Aspergillus ochraceus (ATCC-1008), 
LC-MS/MS and NMR
Cunninghamella
Concentration tolerance and conversion time profiles
Experiments were performed to determine the tolerance of stage II cultures of Actinoplanes sp. to various concentrations of diclofenac, and to determine the progression of metabolism. The culture methods were identical to those used for screening of bacterial metabolism. Aliquots of substrate stock solution were added to stage II cultures to achieve final concentrations of 50 µM, 100 µM, and 500 µM using a 50 mM stock; and 1, 2, 5, and 10 mM using a 500 mM stock. 1 mL aliquots were sampled at indicated time points and analyzed by LC-MS/MS as previously described.
The effect of using a diluted Actinoplanes sp. culture for the conversion of diclofenac was also studied at ambient (22 °C) and 30 °C incubation temperatures. 15 mL of culture medium obtained 24-hours after inoculation of the stage II culture was mixed with 135 mL of fresh SOC in 500 mL Erlenmeyer flasks. Appropriate amounts of substrate stock (400 mM) were added to achieve target final concentrations of 50 µM, 500 µM, 1 mM, and 2 mM. The time profile of the reaction was monitored via LC-MS/MS as described above.
Preparative-Scale Incubation and Chromatography
The scale-up procedure was similar to the microbial screening. Metabolites were produced in a 200 mL stage II Actinoplanes sp. culture (2 × 100 mL in 500 mL were dried over anhydrous MgSO 4 , and solvent was removed on a Rota-vap  to yield a light-yellow oil. The crude oil was purified via flash column chromatography (CombiFlash system, Teledyne ISCO, Lincoln, NE) on a 40g Redi-sep silica cartridge with an isocratic mobile phase (hexanes/ethyl acetate; 6:4) to yield three metabolites.
The isolated metabolites were characterized by LC-MS/MS and NMR.
Hollow Fiber Cartridge (HFC) Reactor Procedures
The composition of an HFC reactor and its operation in a closed-cycle loop is depicted in Figure 1 . An HFC consists of a bundle of capillaries composed of a semi-permeable membrane (molecular cutoff varies with the membrane material) and an extra-capillary space (ECS), all enclosed in a poly-carbonate cylinder. The semi-permeable membrane permits exchange of O 2 , nutrients, substrate, metabolites, and cellular excretory products (with molecular weights below the cutoff) while retaining the microorganism in the ECS.
The capillary bundle is potted on both ends to poly-urethane adapters resulting in a common flow path when connected to an external reservoir. The ECS, between the capillary membranes and inner-walls of the cartridge, is loaded with a microbe culture. A medium (containing O 2 , nutrients, and the substrate) is then continuously circulated at a constant flow rate using a peristaltic pump.
Sterile hollow fiber cartridges containing different semi-permeable membranes (Teflon, C2025; polysulfone, C2011; cellulose, C3008) and the peristaltic pump were obtained from FiberCell systems (Frederick, MD). After assembly of the cartridges, the nonspecific binding of diclofenac to the cellulose and poly-sulfone membranes was first determined. The ECS in each cartridge and the external-reservoir was filled with 15 and 135 mL SOC medium, respectively. The medium was circulated for 10 min at 10 mL/min and diclofenac stock solution was added to the reservoir to achieve a final concentration of 50 µM. Aliquots were sampled after 15 hours and analyzed by LC-MS/MS. The experiment for the Teflon membrane HFC was the same except the ECS and the reservoir was filled with 2 mL and 98 mL of SOC broth, respectively.
The ECS in each HFC was then loaded with the microbial culture and time-profiles for diclofenac turnover were determined. Two sterile 50 mL syringes, one empty and another loaded with 40 mL of stage II Actinoplanes sp. culture were attached to the two ECS This article has not been copyedited and formatted. The final version may differ from this version. ports. The microbial suspension was flushed slowly through the ECS space to the other syringe, back and forth, for 2 min. The cartridge ports were wiped with 70% ethanol and closed. The external reservoir volumes remained the same as described above. The system was equilibrated by starting the flow of medium at 10 mL/min for 5 min, and then diclofenac stock solution (50 µM final concentration in the cellulose and Teflon HFC reactors; 2 mM in the poly-sulfone HFC reactor) was added to the external reservoir.
Aliquots (1 mL) were sampled at different times and analyzed by LC-MS/MS. The same experiment was also conducted with cellulose membrane HFC reactor at 2 mM diclofenac concentration.
Experiments to evaluate the reusability of the HFC reactors were performed at two substrate concentrations (50 and 500 µM) in cellulose membrane cartridges. The microbial suspensions were loaded and the reactors were equilibrated as described above.
19 µL of 400 mM diclofenac stock (50 µM final concentration) was then spiked into the reservoir. The reactions proceeded for 15 hr at ambient temperature (22 °C) after which the contents of the external reservoir were removed and analyzed by LC-MS/MS. The reactors were washed by circulating 100 mL of fresh SOC broth for one hour. Then 135 mL of fresh SOC broth was placed in each reservoir. Medium was recirculated for 5 min and then aliquots were collected and analyzed to ensure minimal carry over from the preceding reactions. The medium was then amended with diclofenac stock and formation of the reaction products was monitored. This cycle was repeated a total of 7 times. The experimental procedure to evaluate the reusability at 500 µM concentrations of diclofenac was slightly modified. The external reservoir containing SOC medium was placed on a hot-plate stirrer with its temperature set to 34 °C so that the temperature of the medium (measured at the reservoir with the pump set at a flow-rate of 10 mL/min) was 30 °C. 188 µL of 400 mM diclofenac stock was added and the reaction proceeded for 36 hours. The reaction was repeated four more times for a total of five cycles with two wash cycles between each reaction.
This article has not been copyedited and formatted. The final version may differ from this version. 
Microorganism screening
Nine of the fifteen microbes screened turned over < 1% of 50 µM diclofenac. A time course of diclofenac consumption from the seven microorganisms that did catalyze turnover is summarized in Table 1 . In the fungi family, the majority of turnover catalyzed by C. elegans, C. echinulata (ATCC -11585a) and B. bassiana occurred after 27 hours of incubation and was complete by 120 hours. The other strain of C. echinulata (ATCC-9244) was less efficient in catalyzing turnover of diclofenac. Of the several bacterial strains tested, S. griseus showed a small amount of turnover while the actinomycete Actinoplanes sp. was very efficient in the catalysis and turned over 100% of the diclofenac within 5 hours. In all cases, diclofenac was primarily mono-hydroxylated at the 4' and 5 positions (labels shown in Table 2 ). Actinoplanes sp. was the microbe chosen for all subsequent experiments.
Shake-flask concentration tolerance and time profiles
Time-profiles of diclofenac turnover when incubated at various concentrations (50 µM -5 mM) with Actinoplanes sp. at 30 °C in a shake-flask are shown in Figure 2 . At concentrations of up to 1 mM, substrate turnover was rapid and complete within 5 hr. The turnover at 2 and 5 mM was complete in 10 and 24 hr, respectively. LC-MS/MS analysis indicated the reaction products predominantly consisted of 4'-OH (R t 10.6 min)
and 5-OH (R t 10.8 min) diclofenac in ratios ranging from 8:2 to 7:3 for all of the tested concentrations. At later time points 4',5-dihydroxy diclofenac (R t 8.2 min) was also formed. Turnover at a substrate concentration of 10 mM was dramatically diminished (0.5% over 48 hr, data not shown) and substantial cell-death was observed.
Scale up of metabolite production and definitive metabolite identification
Three hydroxylated metabolites were isolated from a preparative fermentation of diclofenac (5 mM; 318 mg) with Actinoplanes sp. and characterized by MS and NMR.
The results are summarized in Table 2 , confirmed bis-hydroxylation had occurred at the 4' and 5 positions.
Hollow fiber cartridge reactions
The non-specific binding of diclofenac to HFC reactors with three different semipermeable membrane materials was evaluated in absence of microorganism in ECS.
Non-specific binding to a poly-sulfone membrane HFC reactor was rapid and high with only about 18 % of nominal concentrations of diclofenac unabsorbed at 1 hr and available for biotransformation. The non-specific binding to Teflon and cellulose membrane HFC reactors were substantially lower: 98.5 % and > 85 % diclofenac remaining in both at 1 hr and 5 hr, respectively.
Diclofenac was turned over in all three HFC reactors at ambient temperature to its 4'-OH and 5-OH metabolites, and the results are summarized in Incubations were conducted in shake flasks using the amounts of stage II culture that were used in the cellulose-membrane HFC reactors. The results are presented in Figure   3A . The amounts of stage II culture were matched in the way to provide a more direct comparison of the two techniques. The cellulose HFC reactor holds 15 mL of stage II bacterial culture in a total reaction volume of 150mL, which is an approximately 10-fold lower microbial density than was used in the shake-flask cultures used to determine the time course of turnover shown in Figure 2 . At ambient temperature, 50 µM diclofenac was completely consumed in 24 hr and 500 µM diclofenac required 72 hr. Figure 3B shows results from the same incubations conducted under identical conditions except temperature was 30 °C. The reaction rate was approximately 3 to 4 fold higher at higher temperature. At 1 mM or higher concentrations, the substrate turnover was dramatically lower with < 1% turnover observed at 72 hr. The 4'-OH and 5-OH metabolites were observed approximately in the same ratio as in earlier incubations.
Time profiles of 50 µM diclofenac conversion in a shake-flask and a cellulose-membrane HFC reactor under identical conditions (same amount of stage II culture, 22 °C) is shown in Figure 4 . The progression of turnover appears to be very similar for both techniques.
Reuse of biocatalyst in HFC reactors
Plots of diclofenac turnover versus number of reutilization cycles at 50 µM (at 22 °C, 15 hr, 7 cycles) and 500 µM (at 30 °C, 36 hr, 5 cycles) concentrations are displayed in Figure 5 . At 50 µM concentration, the conversion was > 98% in 15 hr for each reaction.
The ratio of 4'-OH to 5-OH, the two mono-hydroxylated metabolites, changed from 8:2 in cycle number 1 to 6:4 in cycle number 7. The 4',5-dihydroxy metabolite accounted for < 3% of the metabolite products. Carry over, monitored by analyzing the wash medium, was < 1%. At a 500 µM diclofenac concentration, the reaction time to completion (> 98% turnover) was 36 hr and required two wash cycles to reduce the carryover to < 1%. The ratio of 4'-OH to 5-OH metabolite was 7:3 in all cycles and the 4',5-dihydroxy were all reported to be hydroxylations on either an allylic (Kuhnt et al. 1996) or alkyl carbon (Haag et al. 1998; Chen et al. 1993; Hsu et al. 2002; So et al. 1995) ; no aromatic hydroxylations have been previously reported.
A 200 mL scale-up of a shake-flask incubation and isolation of the reaction products yielded three metabolites: 4'-hydroxy, 5-hydroxy, and 4',5-dihydroxy diclofenac. 169 mg of 4'-hydroxy diclofenac was obtained, and a 54 % yield was significantly higher than previously reported bio-reactor scale-ups. Previously obtained yields were 15 % from Epicoccum nigrum (Webster et al. 1998) , 26 % from human CYP450 2C9 expressed in Sf21 insect cells (Rushmore et al. 2000) , and 35 % from human CYP450 2C9 expressed in an Escherichia coli system (Vail et al. 2005) . 5-Hydroxy diclofenac has been previously reported to be formed in fungal incubations (Webster et. al. 1998 ) but was never isolated. It has been isolated from human urine (Stierlin et al. 1979 ) as well as synthesized (Kenney et al. 2004 , Tang et al. 1999 , Bort et al. 1996 . 4',5-dihydroxy diclofenac has also been isolated from human urine (Stierlin et al. 1979 ); however, a microbial or synthetic route has not been previously reported.
The tolerance of Actinoplanes sp. to high concentrations of diclofenac (up to 5 mM, Figure 2 ) in a shake flask nominally appeared to be higher than in the HFC reactor (only up to 500 µM, Figure 3 ). The microbial content was, however, approximately 10 times higher in the shake flask than in the HFC reactor. When the lower microbial content in the HFC reactor was compensated, the rate of 50 µM diclofenac conversion was observed to be similar in both the shake flask and cellulose HFC reactor (Figure 4 ).
Hollow fiber cartridge reactors were demonstrated to turn over substrate and produce metabolites with similar efficiency to shake-flask reactors. They also offer several This article has not been copyedited and formatted. The final version may differ from this version. potential advantages compared to shake-flask configurations. As was demonstrated, the bio-catalyst in an HFC reactor can be re-used many times over. In contrast, the biocatalyst in a shake flask can be used only once because the quenching process kills the microbes. The purification of metabolites biosynthesized in an HFC reactor is also theoretically easier because the products can be harvested from the external medium which is devoid of the cellular matrix.
An HFC reactor potentially offers a readily available system to generate metabolites for multiple compounds over time because there is no theoretical reason to believe that the substrate would have to be the same in each reaction cycle. The recirculation of medium (containing the substrate) in a closed-loop system allows for multiple passes for the substrate to be turned over. The cartridges employed in this report had an ECS volume between 2 and 15 mL and were sufficient to achieve a 100 % turnover of diclofenac (up to 500 µM) in a closed-loop system. Larger volume cartridges are also commercially available (cellulose HFC with a 70 mL ECS, FiberCell Systems) to facilitate scaled up reactions.
The one drawback observed with an HFC reactor is the potential for non-specific binding of substrate. Non-specific binding could occur to any of the components in the reactor.
The three cartridges used in this study all had the same length of silicone tubing and the same cartridge shell. The only differences were in the material that comprised the semipermeable membrane. Differences in the membrane material were probably responsible for the differences observed in non-specific binding. Binding to Teflon and cellulose membranes was substantially less than to the poly-sulfone membrane. The extent to which other substrates (e.g. hydrophobic or basic compounds) might non-specifically bind to these materials was not determined.
To our knowledge, this work represents the first example of an HFC reactor used to produce mammalian CYP450 metabolites using microbial cultures. Previously published examples employing HFC reactors for biochemical reactions include conversions of glucose to ethanol using entrapped Saccharomyces cerevisiae (Inloes et al. 1983 ); Lhistidine to urocanic acid by Pseudomonas fluorescens (Kan and Shuler, 1978) ; and 2-This article has not been copyedited and formatted. The final version may differ from this version. 
